Background:

AB-PINACA N-pentanoic acid metabolite-d₄(CRM) is intended for use as an internal standard for the quantification of AB-PINACA N-pentanoic acid metabolite by GC- or LC-mass spectrometry (MS). AB-PINACA is a synthetic cannabinoid (CB) that has been identified in illegal herbal products.¹AB-PINACA N-pentanoic acid metabolite is an expected compound produced by phase I metabolism of AB-PINACAin vivo, based on the metabolism of comparable alkylindole CBs.^2,3The physiological and toxicological properties of this compound have not been determined. This product is intended for research and forensic applications.

1.Uchiyama, N., Matsuda, S., Wakana, D., et al.New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal productsForensic Toxicol.31(1)93-100(2013) 2.Sobolevsky, T., Prasolov, I., and Rodchenkov, G.Detection of JWH-018 metabolites in smoking mixture post-administration urineForensic Sci. Int.200(1-3)141-147(2010) 3.Chimalakonda, K.C., Moran, C.L., Kennedy, P.D., et al.Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urineAnal. Chem.83(16)6381-6388(2011)